Guardant Health
GH
#1530
Rank
HK$105.25 B
Marketcap
HK$810.45
Share price
2.11%
Change (1 day)
186.43%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$12.69 Billion

According to Guardant Health 's latest financial reports the company's total liabilities are HK$12.69 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$12.61 B-0.75%
2023-12-31HK$12.71 B4.99%
2022-12-31HK$12.10 B-0.42%
2021-12-31HK$12.16 B71.21%
2020-12-31HK$7.10 B696.18%
2019-12-31HK$0.89 B82.41%
2018-12-31HK$0.48 B82.32%
2017-12-31HK$0.26 B-6.18%
2016-12-31HK$0.28 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Natera
NTRA
HK$4.42 B-65.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
HK$9.79 B-22.79%๐Ÿ‡บ๐Ÿ‡ธ USA